Azade Pütz

Artificial intelligence is a highly relevant topic, and for good reason. It has the potential to provide innovative solutions to complex challenges. This is particularly true in the pharmaceutical industry, where implementing and using AI can result in significant benefits. Today's editorial explores the potential of AI applications in the GMP environment and the challenges that could come along with it.
The upcoming LOGFILE will tackle the current regulatory framework for AI, focusing on the EU AI Act, relevant ISO standards, and the EMA's reflection paper on the topic. Don’t miss out and benefit from the concise overview!

Artificial intelligence is developing faster than any previous technology, promising innovation and competitive advantage. Yet, integrating AI while maintaining safety, quality, and trust poses a challenging task for the pharmaceutical industry. It requires an appropriate regulatory framework as a fundamental condition. Today's editorial outlines which role the EU AI Act, the EMA's reflection paper, and various ISO standards play in shaping the regulatory landscape.